{"id":31150,"date":"2017-09-18T12:38:46","date_gmt":"2017-09-18T12:38:46","guid":{"rendered":"https:\/\/www.edristi.in\/?p=31150"},"modified":"2017-09-18T12:38:46","modified_gmt":"2017-09-18T12:38:46","slug":"vasant-narasimhan","status":"publish","type":"post","link":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/vasant-narasimhan\/","title":{"rendered":"Vasant Narasimhan"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Question: Recently, Vasant Narasimhan of Indian origin was appointed Chief Executive Officer (CEO) of which of the following major pharma company? <\/strong><br \/>\n(a) Ranbaxy Laboratories<br \/>\n(b) Novartis<br \/>\n(c) Lupine<br \/>\n(d) Sunpharma<br \/>\n<strong>Answer: (b)<br \/>\nRelated Facts:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>On September 4th, 2017, Vasant Narasimhan of Indian origin was appointed the new Chief Executive Officer (CEO) of the famous Swiss pharma company Novartis.<\/li>\n<li>His tenure will begin on February 1, 2018.<\/li>\n<li>In present he is Global Head of Drug Development and Chief Medical Officer for Novartis since February 1, 2016.<\/li>\n<li>On this post, he will replace Joseph Jimenez.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Reference:<\/strong><br \/>\n<a href=\"https:\/\/www.novartis.com\/news\/media-releases\/novartis-announces-ceo-joseph-jimenez-retire-novartis-2018-vasant-narasimhan\" target=\"_blank\" rel=\"noopener\">https:\/\/www.novartis.com\/news\/media-releases\/novartis-announces-ceo-joseph-jimenez-retire-novartis-2018-vasant-narasimhan<\/a><br \/>\n<a href=\"https:\/\/www.novartis.com\/sites\/www.novartis.com\/files\/cv-vasant-narasimhan-en.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/www.novartis.com\/sites\/www.novartis.com\/files\/cv-vasant-narasimhan-en.pdf<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Question: Recently, Vasant Narasimhan of Indian origin was appointed Chief Executive Officer (CEO) of which of the following major pharma company? (a) Ranbaxy Laboratories (b) Novartis (c) Lupine (d) Sunpharma Answer: (b) Related Facts: On September 4th, 2017, Vasant Narasimhan of Indian origin was appointed the new Chief Executive Officer (CEO) of the famous Swiss [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":31094,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1127],"tags":[2348],"class_list":["post-31150","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pers","tag-personalities"],"_links":{"self":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts\/31150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/comments?post=31150"}],"version-history":[{"count":0,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts\/31150\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/media\/31094"}],"wp:attachment":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/media?parent=31150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/categories?post=31150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/tags?post=31150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}